title: Letter to the editor: reply to Legare et al.
authors.affiliation: Department of Psychiatry, Brain Center Rudolf Magnus, UMC, Utrecht, The Netherlands. Electronic address: roosvanwestrhenen@hotmail.com.
authors.forename: R
authors.initials: R
authors.lastname: van Westrhenen
authors.affiliation: Dept. for Specialized treatments, Center for Bipolar Disorders, Alkmaar, The Netherlands.
authors.forename: P F J
authors.initials: PF
authors.lastname: Schulte
authors.affiliation: Department of Psychiatry, Brain Center Rudolf Magnus, UMC, Utrecht, The Netherlands.
authors.forename: I
authors.initials: I
authors.lastname: Sommer
mesh_terms: D003024:Clozapine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D003024:Clozapine; D016666:Fluvoxamine